Burkina Faso vs Gabon: Antiretroviral therapy coverage for PMTCT
Burkina Faso
69.0%
in 2024
Gabon
72.0%
in 2024
Burkina Faso rank
52nd
Gabon rank
49th
Antiretroviral therapy coverage for PMTCT over time
- Burkina Faso
- Gabon
How they compare
Gabon currently reports 72.0% against 69.0% in Burkina Faso, a difference of 3.0%.
The two have swapped places 8 times across 25 shared years of data; in 2000 it was Gabon ahead.
Burkina Faso ranks 52nd and Gabon ranks 49th of 84 countries.
Burkina Faso has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Burkina Faso | Gabon | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 10.0% | 6.6% | 3.4% | Burkina Faso |
| 2010s | 51.5% | 48.0% | 3.5% | Burkina Faso |
| 2020s | 79.8% | 70.6% | 9.2% | Burkina Faso |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher antiretroviral therapy coverage for pmtct, Burkina Faso or Gabon?
- Gabon, at 72.0% against 69.0% in Burkina Faso as of 2024.
- What is the difference in antiretroviral therapy coverage for pmtct between Burkina Faso and Gabon?
- 3.0%, with Gabon ahead.
- How many years of comparable data are there for Burkina Faso and Gabon?
- 25 years are reported by both, from 2000 to 2024.
- How do Burkina Faso and Gabon rank globally for antiretroviral therapy coverage for pmtct?
- Burkina Faso ranks 52nd and Gabon ranks 49th of 84 countries.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).